Free press releases distribution network?

Agency / Source: In Press PR Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



BBI Group Establishes a Centralised Solution for Diagnostic Critical Reagents & Development Services - From May 1st 2013, BBI Solutions is the new name for four core business entities of The BBI Group as it establishes a centralised solution for diagnostic critical reagents and development services - BBISolutions.com
BBI Group Establishes a Centralised Solution for Diagnostic Critical Reagents & Development Services

 

PRZOOM - /newswire/ - Lambourn, Berkshire, United Kingdom, 2013/05/01 - From May 1st 2013, BBI Solutions is the new name for four core business entities of The BBI Group as it establishes a centralised solution for diagnostic critical reagents and development services - BBISolutions.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The BBI Group announces that from today, four of its core business entities BBInternational, BBI Enzymes, Scipac and Vision Biotech will merge and trade under one brand - BBI Solutions. BBI Solutions will trade alongside BBI Detection and BBI Healthcare as a separate division. As part of this restructure, a new brand identity will be rolled out across all aspects of business communications for all three divisions.

Speaking from the BBI Group’s headquarters in Cardiff, UK, Lyn Rees, Group CEO says: "This is a very exciting time in our company's development. BBI is a name that is synonymous with quality reagents and services and over the past 10 years we have grown significantly and brought a number of high quality organisations into BBI. This is an opportunity for us to bring the strength of these companies into one brand with global sites offering critical reagents and services to the diagnostic, pharmaceutical and consumer healthcare markets.

This development is part of our ongoing strategy to expand our global business in the area of immunoassay design, development and manufacture, while also offering an expanding portfolio of critical reagents, biological products and technologies for a variety of platforms servicing the global diagnostic and pharmaceutical markets.”

Customers of BBI Solutions will now benefit from a streamlined organizational structure. There will be single point access to BBI Solutions’ wide portfolio of biological reagents and immunoassay labels through a web based e-commerce site and an experienced and dedicated account team that can provide support across the entire portfolio of products. Customers can also be assured that the high emphasis on Quality Assurance and Quality Control for which all BBI Group companies are renowned will remain a priority.

Lyn Rees continues ”Our aim is to provide customers with the ability to make their strategic purchases conveniently and safe in the knowledge that they have a strong supply partner that can meet the majority, if not all, of their critical reagent needs both in terms of quality, economy and scale”.

By offering an expanding portfolio of critical reagents and services, the aim of BBI Solutions is to be the number one total diagnostic solution partner for today and tomorrow’s highly accurate, highly reliable point of use diagnostic assays.

Enquiries: Julie Hart. BBI Solutions. T: +44 (0) 2920 747232

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: In Press PR Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


BBI Group Establishes a Centralised Solution for Diagnostic Critical Reagents & Development Services

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Eileen Holmes-Ievers - Inpress.co.uk 
+44(0)14 8867 4200 eileen[.]inpress.co.uk
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any In Press PR Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From In Press PR Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Triggr & Bloom







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today